488 related articles for article (PubMed ID: 10754635)
21. Modulation of human 5-hydroxytryptamine type 3AB receptors by volatile anesthetics and n-alcohols.
Stevens R; Rüsch D; Solt K; Raines DE; Davies PA
J Pharmacol Exp Ther; 2005 Jul; 314(1):338-45. PubMed ID: 15831437
[TBL] [Abstract][Full Text] [Related]
22. Effects of ethanol on recombinant human neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes.
Cardoso RA; Brozowski SJ; Chavez-Noriega LE; Harpold M; Valenzuela CF; Harris RA
J Pharmacol Exp Ther; 1999 May; 289(2):774-80. PubMed ID: 10215652
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effect of gabapentin on N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
Hara K; Sata T
Acta Anaesthesiol Scand; 2007 Jan; 51(1):122-8. PubMed ID: 17073851
[TBL] [Abstract][Full Text] [Related]
24. Oleamide potentiates benzodiazepine-sensitive gamma-aminobutyric acid receptor activity but does not alter minimum alveolar anesthetic concentration.
Yost CS; Hampson AJ; Leonoudakis D; Koblin DD; Bornheim LM; Gray AT
Anesth Analg; 1998 Jun; 86(6):1294-300. PubMed ID: 9620523
[TBL] [Abstract][Full Text] [Related]
25. Ketamine blocks currents through mammalian nicotinic acetylcholine receptor channels by interaction with both the open and the closed state.
Scheller M; Bufler J; Hertle I; Schneck HJ; Franke C; Kochs E
Anesth Analg; 1996 Oct; 83(4):830-6. PubMed ID: 8831330
[TBL] [Abstract][Full Text] [Related]
26. Effect of MK-801 at the human alpha 7 nicotinic acetylcholine receptor.
Briggs CA; McKenna DG
Neuropharmacology; 1996 Apr; 35(4):407-14. PubMed ID: 8793902
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of neuronal nicotinic acetylcholine receptors by the abused solvent, toluene.
Bale AS; Smothers CT; Woodward JJ
Br J Pharmacol; 2002 Oct; 137(3):375-83. PubMed ID: 12237258
[TBL] [Abstract][Full Text] [Related]
28. MK-801 inhibition of nicotinic acetylcholine receptor channels.
Amador M; Dani JA
Synapse; 1991 Mar; 7(3):207-15. PubMed ID: 1715611
[TBL] [Abstract][Full Text] [Related]
29. Nonhalogenated alkane anesthetics fail to potentiate agonist actions on two ligand-gated ion channels.
Raines DE; Claycomb RJ; Scheller M; Forman SA
Anesthesiology; 2001 Aug; 95(2):470-7. PubMed ID: 11506122
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits.
Smothers CT; Woodward JJ
J Pharmacol Exp Ther; 2007 Aug; 322(2):739-48. PubMed ID: 17502428
[TBL] [Abstract][Full Text] [Related]
31. Alpha 4 beta 2 neuronal nicotinic acetylcholine receptors in the central nervous system are inhibited by isoflurane and propofol, but alpha 7-type nicotinic acetylcholine receptors are unaffected.
Flood P; Ramirez-Latorre J; Role L
Anesthesiology; 1997 Apr; 86(4):859-65. PubMed ID: 9105230
[TBL] [Abstract][Full Text] [Related]
32. An electrophysiological study of the effects of propofol on native neuronal ligand-gated ion channels.
Patten D; Foxon GR; Martin KF; Halliwell RF
Clin Exp Pharmacol Physiol; 2001; 28(5-6):451-8. PubMed ID: 11380521
[TBL] [Abstract][Full Text] [Related]
33. The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in Xenopus laevis oocytes: a comparative study.
Pistis M; Belelli D; Peters JA; Lambert JJ
Br J Pharmacol; 1997 Dec; 122(8):1707-19. PubMed ID: 9422818
[TBL] [Abstract][Full Text] [Related]
34. The NR3B subunit does not alter the anesthetic sensitivities of recombinant N-methyl-D-aspartate receptors.
Yamakura T; Askalany AR; Petrenko AB; Kohno T; Baba H; Sakimura K
Anesth Analg; 2005 Jun; 100(6):1687-1692. PubMed ID: 15920196
[TBL] [Abstract][Full Text] [Related]
35. Nonhalogenated alkanes cyclopropane and butane affect neurotransmitter-gated ion channel and G-protein-coupled receptors: differential actions on GABAA and glycine receptors.
Hara K; Eger EI; Laster MJ; Harris RA
Anesthesiology; 2002 Dec; 97(6):1512-20. PubMed ID: 12459679
[TBL] [Abstract][Full Text] [Related]
36. In vitro inhibition of recombinant ligand-gated ion channels by high concentrations of milnacipran.
Ueta K; Suzuki T; Uchida I; Mashimo T
Psychopharmacology (Berl); 2004 Sep; 175(2):241-6. PubMed ID: 14997275
[TBL] [Abstract][Full Text] [Related]
37. Modulation of NMDA receptor function by ketamine and magnesium. Part II: interactions with volatile anesthetics.
Hollmann MW; Liu HT; Hoenemann CW; Liu WH; Durieux ME
Anesth Analg; 2001 May; 92(5):1182-91. PubMed ID: 11323344
[TBL] [Abstract][Full Text] [Related]
38. The diverse actions of volatile and gaseous anesthetics on human-cloned 5-hydroxytryptamine3 receptors expressed in Xenopus oocytes.
Suzuki T; Koyama H; Sugimoto M; Uchida I; Mashimo T
Anesthesiology; 2002 Mar; 96(3):699-704. PubMed ID: 11873047
[TBL] [Abstract][Full Text] [Related]
39. Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block.
Dravid SM; Erreger K; Yuan H; Nicholson K; Le P; Lyuboslavsky P; Almonte A; Murray E; Mosely C; Barber J; French A; Balster R; Murray TF; Traynelis SF
J Physiol; 2007 May; 581(Pt 1):107-28. PubMed ID: 17303642
[TBL] [Abstract][Full Text] [Related]
40. Role of the NMDA receptor NR2B subunit in the discriminative stimulus effects of ketamine.
De Vry J; Jentzsch KR
Behav Pharmacol; 2003 May; 14(3):229-35. PubMed ID: 12799525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
